Price Vision Group
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Price Vision Group sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Price Vision Group: 10 sponsored US clinical trials, 2 recruiting.
Price Vision Group sponsors 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. 1 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Ectasia Corneal, with 1 trials.
Top-decile sponsor footprint
Price Vision Group ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
Corneal Crosslinking for Treatment of Corneal Neovascularization
NCT04787471
Comparison of Standard vs. Accelerated Corneal Crosslinking
NCT03922542
Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection
NCT05136443
Effect of Xen Implantation on the Aqueous Humor Proteome
NCT04141865
Rhopressa for Corneal Edema Associated With Fuchs Dystrophy
NCT04051463
Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration
NCT03971357
Effect of TrueTear Corneal Surface Imaging
NCT03637348
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
NCT01448213
Corneal Crosslinking in Patients With Keratoconus and Post-Refractive Ectasia
NCT01143389
Cross Linking for Treatment of Corneal Infection
NCT00912509
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 6 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the Price Vision Group pipeline
2 recruiting of 10 indexed (20% open); 5 completed (50%).
Phase mix: 1 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Ectasia Corneal (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Price Vision Group: open-pipeline peers nationwide
Peers matched on 10 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Price Vision Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this Price Vision Group page
10 registered trials is a research-attention snapshot, not an endorsement of Price Vision Group or any single study.
- 2 of Price Vision Group's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Ectasia Corneal is the condition Price Vision Group studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Ectasia Corneal trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Price Vision Group pipeline card: 10 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.